• SKIP TO CONTENT
  • SKIP NAVIGATION
  • Patient Resources
    • Clinical Trial Listings
    • What are Clinical Trials?
    • Become a Clinical Trial Volunteer
    • Useful Resources
    • FDA Approved Drugs
  • Professional Resources
    • Research Center Profiles
    • Market Research
    • Benchmark Reports
    • FDA Approved Drugs
    • Training Guides
    • Books
    • eLearning
    • Events
    • Newsletters
    • White Papers
    • SOPs
  • White Papers
  • Clinical Trial Listings
  • Advertise
  • Sign In
  • Create Account
  • Sign Out
  • My Account
Home » Shire joins ABPI

Shire joins ABPI

August 21, 2012
CenterWatch Staff

Specialty biopharmaceutical company Shire has joined the Association of the British Pharmaceutical Industry (ABPI) as a full member.

"Shire is a fast growing company with high ambitions and our U.K. business continues to evolve; we seek to play a role in the development and growth of our industry so joining the ABPI will be one way of contributing to this,” said Nicola Massey vice president and general manager of the U.K. International Speciality Business and Janis Clayton vice president and general manager of the U.K. Human Genetics Therapy Business, Shire. “We are looking forward to working with the ABPI and engaging with their wider membership on issues that are important to all of us but most importantly to fight for the needs of our patients."

Nicola Massey will join the ABPI board of management with immediate effect.

Stephen Whitehead, chief executive of the ABPI, said, "I’m delighted Shire has joined the ABPI. This is a critical time for industry and a very important time for our members. The ABPI provides a strong voice and strong leadership for our members and we are very happy to be supporting Shire as we go forward."

Shire is focused on chronic symptomatic diseases in areas of unmet needs where the impact of their medicines can make an immediate and tangible difference for patients.

    Upcoming Events

    • 05Dec

      Thriving in Clinical Research – Overcoming Common Challenges as a Site: Part 3 – Site Resourcing

    • 14Apr

      MAGI 2024: The Clinical Research Conference

    Featured Products

    • Surviving an FDA GCP Inspection

      Surviving an FDA GCP Inspection: Resources for Investigators, Sponsors, CROs and IRBs

    • Best Practices for Clinical Trial Site Management

      Best Practices for Clinical Trial Site Management

    Featured Stories

    • Jonathan Seltzer

      Thought Leadership: Remote Patient Monitoring Gives New View of Safety in Cardiac Clinical Trials

    • Quality_Compass-360x240.png

      Ask the Experts: Applying Quality by Design to Protocols

    • Obesity Treatment Patient

      Clinical Trials Need Greater Representation of Obese Patients, Experts Say

    • Modernize-360x240.png

      FDA IT Modernization Plan Prioritizes Data-Sharing, AI, Collaboration and More

    Standard Operating Procedures for Risk-Based Monitoring of Clinical Trials

    The information you need to adapt your monitoring plan to changing times.

    Learn More Here
    • About Us
    • Contact Us
    • Privacy Policy
    • Do Not Sell or Share My Data

    Footer Logo

    300 N. Washington St., Suite 200, Falls Church, VA 22046, USA

    Phone 703.538.7600 – Toll free 888.838.5578

    Copyright © 2023. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing